Also known as: Symlin
Pramlintide is a synthetic analog of the hormone amylin, classified under fat loss and metabolic peptides. It is primarily used to enhance glycemic control in individuals with diabetes, but its role in promoting satiety and weight management has garnered significant interest in research circles. As an amylin analog, Pramlintide mimics the natural effects of amylin, a hormone co-secreted with insulin from pancreatic beta cells.
Pramlintide functions by acting on the central nervous system to promote feelings of fullness, thereby reducing food intake. It slows gastric emptying, which leads to a gradual release of glucose into the bloodstream, helping to prevent spikes in blood sugar levels. This dual action not only aids in glycemic control but also contributes to weight loss by decreasing appetite.
Pramlintide serves as a valuable tool in the realm of metabolic peptides, particularly for its role in enhancing satiety and aiding weight management. Its mechanism of action highlights its potential in both appetite regulation and glycemic control, making it a subject of ongoing research in metabolic health.
Last updated: Feb 25, 2026